Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Zhonghua Nan Ke Xue = National Journal of Andrology
|
December 1, 2012
[Deacetylase SIRT1 and vascular endothelial function]
Zan Wan, Wen Yu, Yun Chen, et al.
Asian Journal of Andrology
|
June 25, 2013
Resveratrol, an activator of SIRT1, restores erectile function in streptozotocin-induced diabetic rats
Wen Yu, Zan Wan, Xue-Feng Qiu, et al.
Pharmacogenomics
|
December 7, 2017
NR3C1 gene polymorphisms are associated with steroid resistance in patients with primary nephrotic syndrome
Jie Liu, Zan Wan, Qianqian Song, et al.
Pharmacogenomics
|
September 6, 2019
Gene polymorphisms in <i>VEGFA</i> and <i>COL2A1</i> are associated with response to inhaled corticosteroids in children with asthma
Zan Wan, Yongjun Tang, Qianqian Song, et al.
Oncology Reports
|
December 14, 2018
β‑blockers inhibit the viability of breast cancer cells by regulating the ERK/COX‑2 signaling pathway and the drug response is affected by ADRB2 single‑nucleotide polymorphisms
Wan-Ying Xie, Ruo-Hui He, Jun Zhang, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Zhonghua Nan Ke Xue = National Journal of Andrology
|
December 1, 2012
[Deacetylase SIRT1 and vascular endothelial function]
Zan Wan, Wen Yu, Yun Chen, et al.
Asian Journal of Andrology
|
June 25, 2013
Resveratrol, an activator of SIRT1, restores erectile function in streptozotocin-induced diabetic rats
Wen Yu, Zan Wan, Xue-Feng Qiu, et al.
Pharmacogenomics
|
December 7, 2017
NR3C1 gene polymorphisms are associated with steroid resistance in patients with primary nephrotic syndrome
Jie Liu, Zan Wan, Qianqian Song, et al.
Pharmacogenomics
|
September 6, 2019
Gene polymorphisms in <i>VEGFA</i> and <i>COL2A1</i> are associated with response to inhaled corticosteroids in children with asthma
Zan Wan, Yongjun Tang, Qianqian Song, et al.
Oncology Reports
|
December 14, 2018
β‑blockers inhibit the viability of breast cancer cells by regulating the ERK/COX‑2 signaling pathway and the drug response is affected by ADRB2 single‑nucleotide polymorphisms
Wan-Ying Xie, Ruo-Hui He, Jun Zhang, et al.
Page
of 1